GLP-1 Guide

Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.

MadeMed Review

An in-depth look at MadeMed — compounded semaglutide and tirzepatide from $99/month, with consults, follow-ups and shipping included. Genuinely cheap, LegitScript certified, and with no FDA warning letter. The caveats are the state coverage and the oral option.

MadeMed

Low Entry Pricing
3.9 / 5

MadeMed is a compounded telehealth platform covering GLP-1 weight loss, men's wellness, peptide therapy and NAD+. It operates as IDL Health LLC, with clinicians provided through Xpedicare, LLC, and states that it works with accredited US compounding pharmacies across 40 states.

The pricing is among the most accessible we have reviewed. Oral semaglutide starts at $99/month and injectable tirzepatide from $189/month at the 2.5mg starting dose, with consultations, follow-up care and shipping all free rather than billed separately. There is an optional MadeMed Club membership at $149/year that reduces monthly costs further — worth doing the arithmetic on, because $149 a year only pays for itself at roughly $12/month of savings.

On credentials it does better than much of the category: LegitScript certification, HIPAA compliance, prescribing only after an online consultation with an independent licensed clinician, and — importantly — no FDA warning letter that we could find. Given the FDA has written to dozens of telehealth firms about compounded GLP-1 marketing, a clean record is a real point in its favour.

Two things hold it at 3.9. It serves 40 states, meaning ten are excluded — check yours before starting. And its cheapest headline product is oral semaglutide, where the evidence is weakest: the FDA-approved oral product (Rybelsus) is a specific tablet formulation with an absorption enhancer, and a compounded oral version is not that product and has no published bioavailability data you can inspect. The $189 injectable is the better-understood buy.

Affiliate disclosure: GLP1Drugs.org earns a commission if you sign up through the links on this page. It does not affect our rating, and we have still recommended the injectable over the cheaper oral product. Pricing checked 29 July 2026.

Visit MadeMed
Editor's PickRecommended Partner

Our Top Recommended Provider: CoreAge Rx

After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:

  • Flat-Rate Pricing

    Same cost at every dose level — no price jumps as you titrate up.

  • Verified Pharmacies

    US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.

  • Everything Included

    Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.

💬

Active Community of Members

Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.

Visit CoreAge Rx →

$99

Oral Semaglutide / Month

$189

Injectable Tirzepatide / Month

40

States Served

$0

Consults & Shipping

Plans & Pricing

Published pricing checked 29 July 2026. Club members are stated to save around $20/month on tirzepatide.

ProductRouteFromEvidence baseOur view
Oral semaglutideOral$99/moNo published dataCheapest, weakest evidence
Injectable tirzepatideSubcutaneous$189/moSame active ingredientBest buy here
NAD+ nasal sprayNasal$269/moLimitedLongevity marketing
MadeMed ClubMembership$149/yrOnly worth it above ~$12/mo saved

The spread in that table is the whole decision. Compounded injectable tirzepatide delivers the same active ingredient as Zepbound by the same route, so its pharmacology is well understood even though the product is not FDA-approved. A compounded oral semaglutide lozenge or tablet is a different proposition — cheaper, but without published absorption data, you cannot know what dose is actually reaching you. Paying $90 more a month for the injectable buys you certainty about delivery.

What's Included

Compounded Semaglutide

Oral and injectable forms of the active ingredient in Ozempic and Wegovy — compounded, not FDA-approved

Compounded Tirzepatide

Injectable dual GIP/GLP-1 from $189/month at the 2.5mg starting dose

Free Consultations

Initial consults and follow-up care are included rather than billed separately

Free Shipping

Shipping is free, from what the company describes as accredited US compounding pharmacies

Peptides and NAD+

A separate peptide line and an NAD+ nasal spray at up to $269/month — note many peptides are not FDA-approved for human use

Optional Club Membership

$149/year for ongoing monthly discounts, stated at around $20/month off tirzepatide

Pros & Cons

Pros

  • Among the lowest entry pricing we have reviewed — $99/month oral, $189/month injectable tirzepatide
  • Consultations, follow-up care and shipping are included rather than charged separately
  • LegitScript certified and HIPAA compliant
  • No FDA warning letter found, unlike a dozen providers reviewed on this site
  • Prescribing requires review by an independent licensed clinician
  • Identifiable corporate structure — IDL Health LLC with clinicians via Xpedicare, LLC

Cons

  • Available in 40 states, so ten are excluded — confirm yours before starting
  • The $99 headline product is oral semaglutide, which has no published bioavailability data in compounded form
  • The $149/year Club membership is an upsell that only pays off above roughly $12/month in savings
  • Compounded medications are not FDA-approved or evaluated by the FDA for safety, effectiveness or quality
  • Peptide offerings warrant scrutiny — many peptides marketed in this category are not approved for human use
  • No insurance accepted

Our Verdict

3.9 / 5 — genuinely cheap compounded GLP-1s with consults and shipping included, LegitScript certified and no FDA letter; marked down for ten unserved states and a headline product with the weakest evidence in the range.

MadeMed is a sensible pick for a price-driven buyer, provided you buy the right product. The injectable tirzepatide at $189/month with free consults, follow-ups and shipping is a strong offer, and the clean FDA record plus LegitScript certification put it ahead of several better-known competitors. Two caveats decide whether it suits you: check that your state is among the 40 served, and resist the $99 oral option unless you have discussed absorption with the prescribing clinician — it is the cheapest line on the menu and the one with the least behind it.

Visit MadeMed

Frequently Asked Questions

How much does MadeMed cost?

Checked 29 July 2026: oral semaglutide starts at $99/month, injectable tirzepatide at $189/month for the 2.5mg starting dose, and an NAD+ nasal spray runs up to $269/month. Consultations, follow-up care and shipping are included. An optional MadeMed Club membership costs $149/year and is stated to save around $20/month on tirzepatide programmes — which means it pays for itself only if you stay on treatment for at least eight months. Prices typically rise with dose, so ask what you will pay at your target dose, not just the starting one.

Is the $99 oral semaglutide worth it?

We would spend the extra on the injectable. There is an FDA-approved oral semaglutide product, Rybelsus, but it is a specific tablet formulation containing an absorption enhancer and tested in clinical trials at defined doses. A compounded oral version is not that product, has not been through those trials, and comes with no published bioavailability data. The FDA has also said it has not identified a basis to conclude the approved oral and injectable routes are medically unsuitable in a way a compounded oral product would address. Cheaper, yes — but you cannot verify how much drug is reaching you.

Is MadeMed legitimate?

The signals are reasonable. It holds LegitScript certification, is HIPAA compliant, requires an online consultation with an independent licensed clinician before prescribing, and has an identifiable corporate structure. Most importantly for this category, we searched the FDA warning letter database and found nothing against MadeMed — which matters when roughly a dozen providers listed on this site do have letters for misleading compounded GLP-1 marketing.

Which states does MadeMed serve?

The company states it operates with accredited US compounding pharmacies in 40 states, which means ten are not served. It does not publish the exclusion list prominently, so confirm your own state before paying anything.

Can I still get compounded GLP-1s in 2026?

With more restriction than before. Tirzepatide came off the FDA shortage list in December 2024 and semaglutide in February 2025, and once a drug is no longer in shortage, pharmacies may not routinely compound what amounts to a copy of the commercial product. Patient-specific compounding for a documented clinical need remains lawful, and in April 2026 the FDA proposed excluding semaglutide and tirzepatide from the 503B bulk substances list. Ask what clinical basis supports compounding for you.

What about the peptide programme?

Treat it separately and sceptically. Many peptides marketed by telehealth platforms are not FDA-approved for human use, and some appear on FDA lists of substances that raise safety concerns for compounding. If a peptide is recommended to you, ask exactly which compound it is and whether it is approved for the use being proposed.

Ready to Get Started?

Check your state is one of the 40 served, and do the maths on the $149/year Club membership before adding it.

Visit MadeMed

Medical Disclaimer: This page is for informational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved and are not evaluated by the FDA for safety, effectiveness or quality; compounded oral or sublingual GLP-1 formulations have no FDA-approved equivalent and no published bioavailability data. Many peptides marketed in this category are not approved for human use. GLP-1 medications commonly cause nausea, vomiting, diarrhoea and constipation and carry risks including pancreatitis and gallbladder disease; they are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2, and should not be used in pregnancy. Prescribing is subject to clinician approval and is not guaranteed. Always consult a qualified healthcare provider.

Pricing Note: Prices checked 29 July 2026 and may since have changed. MadeMed states it operates in 40 states; confirm availability for your own state directly.

Affiliate Disclosure: This site may receive compensation from affiliate partners, including MadeMed. This does not influence our editorial content or review ratings.